Surfactant protein B (SP-B
tion of the SP-B locus in mice results in altered surfactant structure and function, leading to respiratory failure within minutes of birth (3, 4) . Similarly, hereditary SP-B deficiency in human infants leads to postnatal respiratory failure that is invariably fatal even with surfactant replacement therapy (5) (6) (7) . Acute SP-B deficiency in the adult lung that results in a decrease of SP-B concentration by 75-80% in the alveolar airspaces also leads to lethal respiratory failure (8) . Collectively, these data indicate that SP-B is absolutely required for postnatal lung function and survival (9) .
SP-B is synthesized as a preproprotein by alveolar type II epithelial cells and non-ciliated bronchiolar (Clara) cells in the lung; however complete processing of the precursor to the biologically active mature peptide occurs only in type II cells (10) . The proprotein traffics through the secretory pathway of the type II cell to the multivesicular body/late endosome compartment where sequential cleavage of the NH 2 -and COOH-terminal peptide domains results in generation of the mature peptide (11) (12) (13) (14) . There is also some evidence that processing of the proprotein may be initiated in the Golgi (15) . Pro-SP-B processing is complex and may involve multiple enzymes and cleavage sites. Proteolytic cleavage of the NH 2 -terminal propeptide was reported previously to be mediated by an aspartyl protease (16) . A novel aspartyl protease with a very restricted expression pattern was reported recently to be localized predominantly to type II cells in the lung and proximal tubule cells of the kidney (17) (18) (19) (20) (21) . The gene encoding this protease, variously referred to as napsin A, kidney-derived aspartic protease-like protein, or TAO2 (herein referred to as napsin), clusters with other type II cell genes in which expression is significantly up-regulated in pulmonary adenocarcinomas (21) (22) (23) . Importantly, expression of napsin was shown to be regulated by TTF-1, a phosphorylated member of the Nkx2 family of homeodomain-containing transcription factors that also regulates the lung-specific expression of SP-B (24) . Mice homozygous for a mutant hypophosphorylation TTF-1 allele (Titf1 PM/PM ) expressed lower levels of mature SP-B peptide and increased levels of proprotein. Consistent with an SP-B processing defect, expression of the gene encoding napsin was down-regulated by ϳ21-fold in Titf1 PM/PM mice and was associated with neonatal lethality (24) . Taken together, these data strongly suggest that napsin plays an important role in processing of the SP-B proprotein. Recently another enzyme, cathepsin H, was also implicated in the processing of the propeptide of SP-B (25) . The current study was therefore undertaken to directly assess the ability of napsin and cathepsin H to process the SP-B proprotein.
MATERIALS AND METHODS
Generation of Napsin Antibody-Type II cells were isolated from adult mouse lungs as described previously (26) , and total RNA was isolated and reverse transcribed. PCR primers were designed based on the published mouse napsin DNA sequence (17, 27) and napsin amplified from type II cell cDNA. The napsin cDNA was subsequently cloned into pET21 (Novagen) and then transformed into Escherichia coli BL21(DE3) cells. Following induction with 0.1 mM isopropyl-␤-D-thiogalactoside for 4 h, recombinant napsin was recovered by extraction of the bacterial pellet with 6 M guanidine in 20 mM Tris, pH 7.9, 500 mM NaCl followed by NTA affinity chromatography, as described previously (28) . Recombinant napsin was dialyzed against TBS (20 mM Tris, pH 7.4, 150 mM NaCl) and injected into rabbits to generate polyclonal antisera as described previously (29) . The napsin antibody was characterized by Western blotting untransfected HEK293 cells or HEK293 cells transiently transfected with the cDNA encoding mouse or human napsin. The specificity of the immunoreaction was confirmed by absorption of the crude antiserum with recombinant napsin prior to Western blotting as described previously (29) .
Electron Microscopy-Fixed cryoprotected frozen lung and kidney tissues from adult mice were processed for immunogold labeling with napsin antibody and protein A gold as described previously in detail (13) .
Generation and Purification of Human Napsin-Human napsin cDNA was cloned in pEGFP-N3 (Clontech). To generate an HA-tagged napsin cDNA (not fused with EGFP), PCR was performed using specific primers to human napsin, 5Ј primer agc gct agc atg tct cca cca ccg ctg ct and 3Ј primer (with a stop codon) cgc gaa ttc tca agc gta gtc tgg gac gtc gta tgg gta ccc ggg gaa ctg cgc ctg cg. As a control vector, the EGFP sequence was removed from pEGFP-N3 using restriction enzymes SalI and NotI and both ends were filled in with Klenow fragment followed by self-ligation. All constructs were subjected to bidirectional sequencing. The control vector or napsin-HA was stably transfected into HEK293 cells using LipofectAMINE (Invitrogen). For stable expression, transfected cells were selected with G418 (Invitrogen) and G418-resistant colonies were analyzed for the expression of napsin by immunoblotting with anti-HA antibody (clone 3F10; Roche Applied Science). Cells were lysed in lysis buffer (phosphate-buffered saline, 20 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1% Elugent (Calbiochem)) at 4°C for 30 min and centrifuged at 12,000 ϫ g at 4°C for 20 min. The supernatant was incubated with anti-HA affinity matrix (Roche Applied Science) at 4°C overnight, and the matrix was washed with lysis buffer six times.
Generation of Recombinant SP-B ⌬c and Cleavage by Napsin and Cathepsin H-The sequence encoding residues 1-279 of the human SP-B proprotein (SP-B ⌬c ) was cloned in-frame with a six-residue COOH-terminal histidine tag and ligated into pVL1393 (BD Biosciences). Recombinant baculovirus was produced by homologous recombination in Spodoptera frugiperda cells as described by McCormack et al. (30) . Fresh monolayers of Trichoplusia ni cells were infected with plaque-purified recombinant virus at a multiplicity of infection of 2 and cultured in serum-free media for 72 h. Recombinant SP-B ⌬C was purified from the culture medium of infected insect cells by NTA affinity chromatography, under nondenaturing conditions, as described previously (28) . Purified recombinant SP-B ⌬C was incubated with immunoprecipitates from the stable transfectants of napsin-HA or empty vector in incubation buffer (0.1 M sodium acetate, 20 mM EDTA, pH 4.7) or with cathepsin H (Biomol Research Laboratories) in incubation buffer (0.1 M sodium phosphate, 1 mM EDTA, 10 mM cysteine, pH 6.8) at 37°C for 2 h. Pepstatin A was added at 50 ng/l as indicated.
Generation of Recombinant Human SP-B/EGFP in Bacteria and Cleavage by Napsin and Cathepsin H-EGFP cDNA was amplified by PCR using pEGFP-N3 (Clontech) as a template followed by cloning into pET28a (Novagen) at the EcoRI and HindIII sites. Human SP-B fragments (amino acids 146 -207, 272-298, 294 -320, and 318 -381) were amplified by PCR from the human SP-B cDNA and cloned in-frame with EGFP at the NheI and EcoRI sites. The sequences of the constructs were confirmed bidirectionally. BL21(DE3) was transformed with the constructs and protein synthesis was induced by 1 mM isopropyl-␤-Dthiogalactoside. Recombinant SP-B/EGFP fusion protein was purified by NTA affinity chromatography. All recombinant proteins were synthesized as soluble proteins in bacteria. Purified recombinant SP-B/ EGFP was incubated with immunoprecipitates from the stable transfectants of napsin-HA or empty vector in incubation buffer (0.1 M sodium phosphate, pH 6.5) or with cathepsin H in incubation buffer (0.1 M sodium phosphate, 1 mM EDTA, 10 mM cysteine, pH 6.8) at 37°C for 2 h. The reaction products were subjected to SDS-PAGE followed by gel transfer to polyvinylidene difluoride membrane. The membrane was stained with Coomassie Brilliant Blue, and individual bands were cut out from the membrane and subjected to Edman degradation (Protein Analysis Center, Karolinska Institute).
Western Blotting-Samples were resolved on 16.5 or 10 -20% Tris/ Tricine SDS-polyacrylamide gels and transferred to nitrocellulose membranes. Western blotting was performed with antiserum directed against recombinant mouse napsin, antiserum 28031 directed against the mature SP-B peptide, antiserum 55522 directed against the NH 2 -and COOH-terminal propeptides of SP-B (29), and antiserum 76694 directed against the mature SP-C peptide (31) . The membranes were washed with phosphate-buffered saline containing 0.1% Tween 20 (Sigma) and incubated with horseradish peroxidase-conjugated antirabbit Ig (Amersham Biosciences). The membranes were washed, and peroxidase activity was developed by SuperSignal West Pico (Pierce). The intensity of the signal was analyzed by IMAGEQUANT 5.0 (Amersham Biosciences).
siRNA-Mouse napsin-specific siRNAs were synthesized with the silencer siRNA construction kit (Ambion) according to the manufacturer's protocol. The target sequences of the two most effective siRNAs were as follows: siRNA2, aat ctt aaa ccc act gaa tgg, and siRNA3, aac tat tgg ttt ggg aac gcc. Cathepsin H siRNA was synthesized by Cenix Bioscience. The target sequences of the three most effective siRNAs were as follows: cath182, aag gaa gat tca agc cca caa; cath206, aag gaa cca cac att taa aat; cath362, aag gaa gaa agg aaa tgt tgt. As a control, glyceraldehyde-3-phosphate dehydrogenase siRNA was synthesized according to the manufacturer's protocol. Mouse type II cells were isolated from 6-week-old female C57/6 mice as described previously (26) . Transfection of synthesized siRNAs was performed with GeneSilencer Reagent (Gene Therapy Systems). The transfection was carried out with 100 nM siRNA and 5 l of Gene Silencer Reagent in a 12-well plate.
RESULTS

Napsin Expression in Mouse Lung and Kidney Tissues-
Western blotting with an antibody directed against bacterially derived recombinant mouse napsin detected a single immunoreactive protein in HEK293 cells transfected with the cDNA encoding mouse napsin but not in untransfected cells (Fig. 1A) . Absorption of the antiserum with recombinant napsin prior to Western blotting completely blocked the immunoreaction. Napsin was readily detected by Western blotting of the adult mouse lung and kidney homogenates or lysates of type II cells isolated from adult mouse lung. However napsin was considerably more abundant in kidney tissue because immunoreactive protein was detected with less than 1 g of kidney homogenate, whereas at least 30 g of lysate from a purified population of type II cells was required to detect the protein (not shown). Western blotting of fetal lung homogenates detected napsin as early as day 16 of gestation, 1 day prior to the onset of SP-B expression and processing in fetal lung (32) (Fig. 1B) .
The subcellular localization of napsin was characterized by immunoelectron microscopy. In stably transfected HEK293 cells (not shown) and mouse kidney epithelial cells, lysosomes were heavily labeled with the napsin antibody ( Fig. 2A) . In type II cells of the lung, napsin was localized to lamellar bodies (Fig.  2B) , which belong to the family of lysozyme-related organelles (33) and multivesicular bodies (Fig. 2C) . Labeling was somewhat more prominent in multivesicular bodies but was considerably less intense than the labeling of lysosomes in kidney epithelial cells, consistent with the results of Western blotting. Napsin was also detected in lysosomes of alveolar macrophages (not shown) as reported previously (19) . Napsin was not detected in type I epithelial cells or bronchiolar Clara cells.
Cleavage of the NH 2 -and COOH-terminal Propeptide of SP-B by Napsin and Cathepsin H-To
determine whether napsin was involved in proteolytic processing of the SP-B proprotein, mouse type II epithelial cells were labeled with 35 [S]methionine/cysteine for 3 h. The medium containing secreted SP-B proprotein was recovered and immunoprecipitated with an antibody directed against the mature SP-B peptide (Fig. 3 ).
Immunoprecipitates were subsequently incubated with a crude membrane preparation isolated from untransfected HEK293 cells or cells stably transfected with the napsin cDNA. SP-B proprotein, M r ϭ 42,000, and a major processing intermediate (M r ϭ ϳ25,000) were detected in untreated medium, as well as medium treated with membrane extract from transfected and untransfected cells (Fig. 3) . Both membrane extracts processed the proprotein; however, only the membrane extract from napsin-transfected cells produced an increase in the M r ϳ25,000 processing intermediate and in smaller peptides that were immunoprecipitated with the SP-B mature peptide antibody (Fig. 3, lane T) .
The M r ϭ 25,000 SP-B processing intermediate was shown previously to arise by removal of the NH 2 -terminal propeptide (11, 12, 16) . To assess the role of napsin in the processing of the NH 2 -terminal propeptide, recombinant pro-SP-B lacking the entire 102-amino acid COOH-terminal domain (SP-B ⌬C ) was isolated from the medium of baculovirus-infected insect cells.
Human napsin with an HA tag was expressed in HEK293 cells and purified by immunoprecipitation using an anti-HA affinity matrix. Recombinant SP-B ⌬C was incubated with immunopurified napsin for 2 h (pH 4.7, 37°C) in the presence or absence of pepstatin A, an inhibitor of aspartic proteinases, or with cathepsin H for 2 h (pH 6.8, 37°C). Western blotting showed that SP-B ⌬C was cleaved by napsin and that this cleavage was complete and inhibited by pepstatin A (Fig. 4) . Cathepsin H similarly cleaved SP-B ⌬C to generate a peptide that migrated with M r ϭ 11-12,000 (Fig. 4) . The additional 28-kDa band in the cathepsin H reaction is related to cross-reactivity of the primary or secondary antibody with cathepsin H (Fig. 4 , compare lane 4 with lane 6). The cleaved peptides were detected by an antibody directed against the mature SP-B peptide, and both cleaved peptides were larger than the mature peptide (M r ϭ 9000), indicating that napsin and cathepsin H cleaved within the SP-B propeptide upstream of the NH 2 terminus of the mature peptide.
Because sufficient material was not obtained for sequencing of the cleavage site, recombinant human SP-B peptides fused to EGFP were produced in bacteria. All recombinant proteins were produced as soluble proteins in bacteria. The SP-B 146 -207 / EGFP fusion protein included the 55 residues between the saposin-like domain in the NH 2 -terminal propeptide and the mature peptide as well as the first 7 residues of mature SP-B (Fig. 5) . Incubation of purified SP-B 146 -207 /EGFP with immunopurified napsin for 2 h (pH 6.5, 37°C) resulted in the generation of a peptide with M r ϳ33,000 (Fig. 5) . Amino acid sequence analysis of the recovered peptide fragment showed that napsin cleaved the SP-B 146 -207 /EGFP fusion protein between Leu 178 and Pro 179 , 22 amino acids upstream from the NH 2 terminus of the mature peptide. The calculated molecular mass of mature SP-B with an NH 2 -terminal extension of 22 residues is 11.1 kDa, a value that is in good agreement with the results of the napsin-mediated cleavage of SP-B ⌬c purified from insect cell medium (Fig. 4) . The incubation of SP-B 146 -207 /EGFP fusion protein with cathepsin H also resulted in cleavage within the propeptide. Amino acid sequence analysis showed that cathepsin H cleaved the fusion protein between Ala 187 and Arg 188 , 13 amino acids upstream of the NH 2 terminus of the mature peptide (Fig. 6) . Thus, cathepsin H cleaved between the S-labeled SP-B were immunoprecipitated with an antibody that detects the mature SP-B peptide. Immunoprecipitates were recovered and resuspended in buffer, pH 4.7, and then incubated with a membrane fraction that was isolated from untransfected (uT) or transfected (T) HEK293 cells as described by Schauer-Vukasinovic et al. (20) or incubated without membranes (C) for 2 h at 37°C. Immunoprecipitates were washed and then analyzed by SDS-PAGE/autoradiography. napsin cleavage site and the NH 2 terminus of mature SP-B but did not generate the NH 2 terminus of the mature peptide.
The ability of napsin and cathepsin H to generate the COOH terminus of the SP-B mature peptide was also tested. An SP-B fragment (SP-B 272-298 ), consisting of the last eight amino acids of the mature SP-B and the 19 residues between the mature peptide and the saposin-like domain in the COOH-terminal domain of the proprotein, was expressed in-frame with EGFP (Fig. 7) (Fig. 7) . To further determine whether napsin or cathepsin H could cleave at other positions within the COOH-terminal peptide, we synthesized two more SP-B/EGFP fusion proteins covering the remainder of the COOH-terminal domain of pro-SP-B (Fig. 7, SP . In summary, napsin processing is restricted to the NH 2 -terminal propeptide, whereas cathepsin H is involved in the processing of both the NH 2 -and COOH-terminal domains of pro-SP-B (Fig. 8) .
Knockdown of Napsin and Cathepsin H in Type II Cells-The biologic relevance of napsin-mediated processing of the SP-B proprotein was assessed by inhibiting napsin expression in the primary cultures of mouse type II cells (Fig. 9) . Preliminary experiments with fluorescent siRNA probes indicated that more than 90% of type II cells were routinely transfected with these reagents. Five different napsin siRNAs were synthesized and transfected into isolated type II cells. Two siRNA sequences were subsequently selected based on their ability to suppress napsin protein levels relative to the control glyceraldehyde-3-phosphate dehydrogenase siRNA or transfection reagent alone (Fig. 9) . The siRNA-mediated decrease in napsin protein was accompanied by a decrease in the level of SP-B mature peptide in type II cells after 2 days of culture. The concentration of SP-C mature peptide was also decreased. There was no evidence of siRNA-mediated cytotoxicity (i.e. increased lactate dehydrogenase release), and the concentration of other proteins (e.g. SP-A) was not affected (not shown). These data suggest that napsin plays a key role in processing the SP-B proprotein to the biologically active mature peptide.
Knockdown experiments were also attempted with five siRNA sequences for cathepsin H. The most effective of these siRNAs decreased cathepsin H protein levels to 40% of those in control cells; however the pattern of SP-B processing and the concentration of mature peptide were not altered (not shown).
DISCUSSION
Processing of SP-B occurs during transit through the secretory pathway in type II epithelial cells. We have reported previously (16) that a membrane-associated aspartic proteinase is involved in the processing of SP-B. Napsin is a membrane-associated aspartyl protease with a very restricted pattern of expression (19, 20) . In the present study, we localized napsin to the lamellar bodies and multivesicular bodies of type II epithelial cells in concordance with reports from other groups (19, 34) . This specific subcellular localization supports the hypothesis that napsin is involved in processing of the SP-B proprotein. In addition, napsin expression was detected as early as day 16 of gestation in the fetal lung, which is consist- / EGFP was incubated with cathepsin H, pH 6.8, at 37°C for 2 h. The proteins were separated by SDS-PAGE followed by transfer to polyvinylidene difluoride membrane. The membrane was stained with Coomassie Brilliant Blue, and the cleaved peptide fragment was analyzed by Edman degradation. GFP, green fluorescent protein.
ent with the time of onset (day 17) of SP-B expression and processing. This is also consistent with a previous study that detected weak expression of napsin mRNA on day 15 with increased intensity on day 16 (18) .
We employed three types of experiments to show that napsin is capable of cleaving the SP-B proprotein. In the first experiment, SP-B proprotein from the medium of type II cell cultures was incubated with a crude membrane fraction from napsintransfected or untransfected HEK293 cells. The levels of the 25-kDa intermediate were enhanced after incubation with the membrane extract from napsin-transfected cells, suggesting that napsin is involved in the generation of this intermediate. /EGFP, and SP-B 318 -381 /EGFP were incubated with immunopurified napsin, pH 6.5, or with cathepsin H, pH 6.8, at 37°C for 2 h. The proteins were separated by SDS-PAGE followed by transfer to polyvinylidene difluoride membrane. The membrane was stained with Coomassie Brilliant Blue, and the cleaved peptide fragments were analyzed by Edman degradation.
FIG. 8. Summary of napsin and cathepsin H cleavage sites in human SP-B proprotein.
Processing of Pro-SP-B by Napsin and Cathepsin H 16182
Small amounts of lower molecular mass polypeptides (16 and 19 kDa) were also observed after incubation with membrane extracts from napsin-transfected cells. These forms may arise from cleavage of the 25-kDa polypeptide by napsin. Alternatively, accumulation of the-25 kDa intermediate may facilitate further cleavage by other enzyme(s) present in the membrane extract. In the second experiment, recombinant SP-B ⌬c was produced in baculovirus-infected insect cells. SP-B ⌬c was shown previously to be completely processed to the biologically active mature peptide in transgenic mice (35) . When expressed in insect cells, SP-B ⌬c was secreted into the medium, suggesting that the quality control apparatus in the secretory pathway recognized the recombinant protein as being correctly folded. Incubation of recombinant SP-B ⌬c with purified human napsin generated a peptide that was slightly larger than mature SP-B and was detected by an antibody directed against the mature peptide, indicating that napsin cleaved pro-SP-B within the NH 2 -terminal propeptide. In the third experiment, a recombinant human pro-SP-B peptide was produced as a soluble EGFP fusion protein in E. coli. We have shown previously that the expression of recombinant SP-B ⌬c in bacteria resulted in an insoluble recombinant protein likely related to the complex folding requirements of the saposin-like domain in the propeptide (28) . Previous analyses using a fluorescent resonance energy transfer-based approach demonstrated that human napsin cleaved between hydrophobic residues with a preference for Leu at position P1 (36, 37) . The results of the current study conform to this pattern and indicated that human napsin cleaved between two hydrophobic amino acids, Leu 178 and Pro 179 . In contrast, five other Leu-Pro sites in the SP-B 146 -207 / EGFP fusion protein were not cleaved, suggesting that these sites were inaccessible and/or that neighboring residues produced an unfavorable context for cleavage. Napsin also did not cleave any of the COOH-terminal peptide-EGFP fusion proteins. These results differ significantly from the recent study of Brasch et al. (34) who detected multiple cleavage sites when napsin was incubated with a refolded full-length recombinant SP-B substrate; napsin-mediated cleavage was detected immediately after Val 180 and Ala 184 in the propeptide, Ala 276 in the mature peptide, and Trp 354 in the COOH-terminal peptide domain of the proprotein. In the present study, napsin cleaved within the NH 2 -terminal propeptide but did not cleave within the mature peptide or the COOH-terminal domain. As suggested by Brasch et al. (34) , napsin-mediated cleavage of the mature peptide in their study may have been the result of inappropriate refolding of bacterially produced SP-B protein leading to exposure of non-native cleavage sites. Alternatively, differences in incubation conditions, preparation of recombinant SP-B, or enzyme preparation may have contributed to the discrepancies between these two studies.
A cysteine protease, most likely cathepsin H, was suggested FIG. 9 . Reduced levels of mature SP-B and mature SP-C by napsin siRNAs. Mouse type II cells in primary cell culture were transfected with napsin siRNAs or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) siRNA using the GeneSilencer Reagent (GS). After 2 days of culture, cell lysates were analyzed by SDS-PAGE/Western blotting with the indicated antibodies. Actin expression is shown for loading control. Signal intensities were analyzed by densitometry, and the ratios of mature SP-B to actin and mature SP-C to actin were plotted.
to be involved in the final step of SP-B processing (25) . Cathepsin H, like napsin, was shown to be localized to lamellar bodies, and multivesicular bodies of type II cells (39 -41) , consistent with the endopeptidase activity of cathepsin H. This result shows that at least one more enzyme, in addition to napsin and cathepsin H, is involved in generation of the NH 2 terminus of mature SP-B. Interestingly, in contrast to napsin, cathepsin H also cleaved the COOH-terminal peptide of SP-B at several sites. The cleavage sites by napsin and cathepsin H are summarized in Fig. 8 . Importantly, one of the cleavage sites was the boundary between mature SP-B and the COOH-terminal domain, suggesting that cathepsin H is involved in the final step of the COOHterminal processing of pro-SP-B. The biologic relevance of the other COOH-terminal cleavages sites remains unclear.
A siRNA experiment was performed to determine whether napsin is required for the cellular processing of pro-SP-B. Decreased levels of mature SP-B were accompanied by the knockdown of napsin, indicating an important role for napsin in the processing of pro-SP-B. Accumulation of the 42-kDa proprotein was not detected in treated or untreated type II cells in these experiments (not shown). This is not unexpected, because we have never been able to detect pro-SP-B by Western blotting (except following lung injury) presumably because the proprotein is rapidly processed or degraded. We also observed decreased levels of mature SP-C in the presence of napsin siRNA. Because SP-B expression is required for processing of SP-C, decreased levels of mature SP-C may result from deficiency of mature SP-B (3, 5, 6, 42) . A direct involvement of napsin in pro-SP-C processing cannot, however, be excluded at present. Recent investigations have shown that siRNA can activate the interferon pathway leading to complications in the interpretation of such experiments (43, 38) . We used glyceraldehyde-3-phosphate dehydrogenase siRNA, expected to activate nonspecific pathways to the same extent as napsin siRNA, as a negative control. Results are expressed in relation to this control and suggest that decreased levels of mature SP-B and mature SP-C are not because of nonspecific activity but because of decreased expression of napsin.
Comparable siRNA experiments for cathepsin H were not conclusive, presumably because we were unable to achieve complete inhibition of enzyme expression. Although it is possible that cathepsin H is not involved in SP-B processing in vivo, the finding that cathepsin H cleavage generates the exact COOH terminus of the mature peptide argues strongly that this is a biologically relevant processing event.
In conclusion, it is clear from this study and those of Brasch et al. (34) that multiple proteolytic enzymes are involved in generating the biologically active SP-B mature peptide. Our data suggest that napsin is essential for pro-SP-B processing and may be the aspartyl protease involved in generating the 25-kDa pro-SP-B intermediate implicated in the earlier study (16) . Cathepsin H generates the COOH terminus of mature SP-B and may also be involved in processing of the propeptide. The identity of the enzyme(s) responsible for generation of the NH 2 terminus of the biologically active peptide remains unknown.
